Retatrutide × NextGen Peptides - Lab Test, January 2025
Test results
About this test
GLP-1 RT 11.37mg from NextGen Peptides achieves 99.432% purity according to this independent HPLC analysis with UV detection coupled to mass spectrometry. The test was conducted by Freedom Diagnostics Testing on January 1, 2025.
Retatrutide is a triple GIP/GLP-1/glucagon receptor agonist researched for metabolic regulation, weight management, and glycemic control. A purity level of 99.432% demonstrates pharmaceutical-grade synthesis with minimal contamination and high product consistency.
The certificate of analysis (COA #2512310156) is available for download and includes chromatographic data and mass spectrometry confirmation. The sample appears as a white lyophilized powder.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.